Interleukin-23 Antagonist [EPC]

Interleukin-23 Antagonist [EPC] was reported 104720 times

Drugs of the Interleukin-23 Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 414 0.6198
1 SWOLLEN JOINT COUNT INCREASED 1922 0.6021
2 RHEUMATIC FEVER 2543 0.5699
3 LUPUS VULGARIS 682 0.5413
4 DEEP VEIN THROMBOSIS POSTOPERATIVE 1066 0.5322
5 C-REACTIVE PROTEIN 492 0.5307
6 RHEUMATOID FACTOR POSITIVE 2982 0.5157
7 SWOLLEN JOINT COUNT 128 0.5120
8 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 3625 0.5054
9 GRIP STRENGTH 113 0.4934
10 RED BLOOD CELL SEDIMENTATION RATE 127 0.4552
11 FACET JOINT SYNDROME 1431 0.4391
12 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 883 0.4257
13 DUODENAL ULCER PERFORATION 3156 0.4240
14 X-RAY ABNORMAL 735 0.4106
15 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 216 0.3850
16 RETINITIS 661 0.3823
17 DISLOCATION OF VERTEBRA 838 0.3671
18 ILEOCAECAL RESECTION 123 0.3576
19 NEUROLOGIC NEGLECT SYNDROME 178 0.3201
20 HELICOBACTER INFECTION 3256 0.3165
21 PEMPHIGUS 3944 0.3151
22 HAND DEFORMITY 4061 0.3093
23 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 32 0.3048
24 C-REACTIVE PROTEIN ABNORMAL 1789 0.2786
25 MUSCLE INJURY 2219 0.2675
26 PERIPHERAL VENOUS DISEASE 1080 0.2642
27 SERONEGATIVE ARTHRITIS 298 0.2600
28 SYNOVITIS 4640 0.2571
29 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1654 0.2544
30 FOLLICULITIS 2611 0.2487
31 PERICARDITIS 3881 0.2308
32 CONTRAINDICATION TO VACCINATION 42 0.2199
33 BONE EROSION 777 0.2195
34 ILEECTOMY 72 0.2136
35 CAROTID ARTERY THROMBOSIS 181 0.2132
36 HYPOCHOLESTEROLAEMIA 65 0.1841
37 GLOSSODYNIA 4074 0.1818
38 PROCTOCOLECTOMY 55 0.1803
39 GRANULOMA SKIN 143 0.1742
40 ENTHESOPATHY 272 0.1738
41 DRUG TOLERANCE DECREASED 472 0.1679
42 PORPHYRIA ACUTE 236 0.1645
43 BREAST CANCER STAGE III 1042 0.1607
44 LIP DRY 1461 0.1607
45 OVERLAP SYNDROME 106 0.1514
46 WOUND 4231 0.1512
47 HYPERCHOLESTEROLAEMIA 1353 0.1400
48 JOINT RANGE OF MOTION DECREASED 1829 0.1362
49 ADJUSTMENT DISORDER 176 0.1354
50 TERMINAL ILEITIS 83 0.1352
51 WOUND INFECTION 1478 0.1348
52 GRIP STRENGTH DECREASED 1176 0.1335
53 SYRINGE ISSUE 2297 0.1311
54 INTESTINAL ANASTOMOSIS 84 0.1304
55 ONYCHOMADESIS 525 0.1250
56 FAECAL CALPROTECTIN ABNORMAL 51 0.1229
57 PUSTULAR PSORIASIS 421 0.1225
58 ANASTOMOTIC STENOSIS 45 0.1210
59 SYSTEMIC LUPUS ERYTHEMATOSUS 4292 0.1208
60 IRRITABLE BOWEL SYNDROME 2550 0.1188
61 DEATH NEONATAL 156 0.1121
62 BURSITIS 1347 0.1109
63 AUTOIMMUNE DISORDER 1080 0.1107
64 LIVE BIRTH 922 0.1101
65 PSORIATIC ARTHROPATHY 4423 0.1089
66 BLOOD PARATHYROID HORMONE DECREASED 158 0.1065
67 ERYTHRODERMIC PSORIASIS 84 0.1019
68 ARTHRITIS ENTEROPATHIC 33 0.1012
69 FIBROMYALGIA 2434 0.1000
70 BLEPHAROSPASM 615 0.0976
71 TENOSYNOVITIS 267 0.0967
72 CONTRAINDICATED PRODUCT ADMINISTERED 2912 0.0961
73 INTESTINAL RESECTION 513 0.0953
74 LOWER RESPIRATORY TRACT INFECTION 4259 0.0936
75 JOINT ANKYLOSIS 53 0.0933
76 ONYCHOMYCOSIS 403 0.0918
77 ILEAL STENOSIS 160 0.0899
78 SMALL INTESTINAL RESECTION 104 0.0892
79 EXOSTOSIS 804 0.0880
80 ALANINE AMINOTRANSFERASE ABNORMAL 185 0.0876
81 LUPUS-LIKE SYNDROME 784 0.0864
82 TYPE 2 DIABETES MELLITUS 2906 0.0862
83 INFECTED FISTULA 46 0.0858
84 LIVER INJURY 2101 0.0855
85 ILEOSTOMY 210 0.0822
86 IMPAIRED HEALING 2668 0.0812
87 DEVICE DEFECTIVE 1399 0.0806
88 LATENT TUBERCULOSIS 168 0.0802
89 THERAPEUTIC PRODUCT EFFECT DECREASED 3555 0.0793
90 SCIATICA 1263 0.0791
91 INFUSION RELATED REACTION 5240 0.0790
92 FINGER DEFORMITY 373 0.0769
93 RED BLOOD CELL SEDIMENTATION RATE INCREASED 849 0.0767
94 POSTOPERATIVE ABSCESS 51 0.0761
95 FAECAL CALPROTECTIN INCREASED 238 0.0751
96 OBESITY 1178 0.0739
97 ANAL ABSCESS 397 0.0736
98 NEEDLE ISSUE 2138 0.0734
99 ARTHROPATHY 4078 0.0733
100 ANAL STENOSIS 39 0.0732
101 HIP ARTHROPLASTY 1088 0.0710
102 NAIL DISORDER 619 0.0707
103 PANNICULITIS 171 0.0706
104 WALKING AID USER 461 0.0698
105 RECTAL ABSCESS 116 0.0691
106 JOINT DISLOCATION 727 0.0687
107 PRODUCT LEAKAGE 385 0.0685
108 PERSONALITY DISORDER 178 0.0679
109 HEPATIC ENZYME INCREASED 4538 0.0665
110 COLECTOMY TOTAL 37 0.0663
111 ILEAL ULCER 66 0.0652
112 GUTTATE PSORIASIS 53 0.0646
113 FOOT DEFORMITY 709 0.0639
114 MATERNAL EXPOSURE TIMING UNSPECIFIED 238 0.0633
115 SPONDYLITIS 230 0.0632
116 PULMONARY FIBROSIS 1212 0.0631
117 LOWER LIMB FRACTURE 1189 0.0618
118 COLECTOMY 347 0.0614
119 LARGE INTESTINAL STENOSIS 120 0.0600
120 RHEUMATOID NODULE 165 0.0598
121 DEVICE DEPLOYMENT ISSUE 751 0.0587
122 PRESCRIBED OVERDOSE 1109 0.0573
123 BLOOD CHOLESTEROL INCREASED 2655 0.0569
124 INTESTINAL STENOSIS 240 0.0568
125 DISCOMFORT 3465 0.0567
126 CUTANEOUS T-CELL LYMPHOMA 70 0.0556
127 ABSCESS INTESTINAL 119 0.0552
128 SACROILIITIS 104 0.0551
129 DRUG SPECIFIC ANTIBODY 75 0.0547
130 PRODUCT LABEL CONFUSION 317 0.0543
131 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 127 0.0535
132 BLISTER 2921 0.0520
133 PYODERMA GANGRENOSUM 186 0.0517
134 BREAST CANCER STAGE II 426 0.0512
135 INTESTINAL OPERATION 81 0.0511
136 PSORIASIS 6639 0.0508
137 ANAL FISTULA 270 0.0506
138 KNEE ARTHROPLASTY 1063 0.0504
139 HEPATIC CIRRHOSIS 942 0.0501
140 GROIN ABSCESS 59 0.0500
141 RASH VESICULAR 242 0.0500
142 DACTYLITIS 49 0.0499
143 GAIT INABILITY 1660 0.0496
144 INFUSION SITE REACTION 148 0.0495
145 STOMA CREATION 34 0.0490
146 ENTEROCUTANEOUS FISTULA 43 0.0488
147 EYE INJURY 148 0.0487
148 SMALL INTESTINAL STENOSIS 51 0.0479
149 STENOSIS 90 0.0479
150 INTESTINAL FISTULA 67 0.0476
151 TREATMENT FAILURE 3937 0.0475
152 SUSPECTED OFF LABEL USE 214 0.0473
153 BACK INJURY 507 0.0466
154 OSTEOARTHRITIS 1967 0.0463
155 RHEUMATOID LUNG 44 0.0461
156 ULCER HAEMORRHAGE 312 0.0461
157 DRUG INTOLERANCE 4329 0.0448
158 PERFORATION 36 0.0447
159 STOMATITIS 2693 0.0444
160 CHOLANGITIS SCLEROSING 91 0.0443
161 NIGHT SWEATS 1410 0.0437
162 SWELLING 4071 0.0435
163 C-REACTIVE PROTEIN INCREASED 1582 0.0434
164 RHEUMATOID ARTHRITIS 4922 0.0433
165 PRODUCT OUTER PACKAGING ISSUE 39 0.0431
166 LOSS OF THERAPEUTIC RESPONSE 137 0.0429
167 PRESCRIBED UNDERDOSE 833 0.0417
168 LIVER FUNCTION TEST INCREASED 891 0.0415
169 INFLAMMATION 2110 0.0408
170 POUCHITIS 35 0.0407
171 GASTROENTERITIS NOROVIRUS 54 0.0406
172 MOBILITY DECREASED 2917 0.0406
173 JOINT SWELLING 4798 0.0397
174 TUBERCULIN TEST POSITIVE 100 0.0395
175 BONE CYST 37 0.0394
176 INJURY 2753 0.0391
177 ABDOMINAL ABSCESS 172 0.0389
178 GASTROINTESTINAL WALL THICKENING 58 0.0387
179 DRUG DELIVERY SYSTEM MALFUNCTION 198 0.0387
180 FISTULA 431 0.0383
181 FISTULA DISCHARGE 48 0.0380
182 COLITIS ULCERATIVE 1695 0.0379
183 COELIAC DISEASE 371 0.0378
184 CONGENITAL ANOMALY 290 0.0374
185 MUSCULOSKELETAL STIFFNESS 3255 0.0371
186 EXPOSURE DURING PREGNANCY 2306 0.0371
187 BASAL CELL CARCINOMA 574 0.0368
188 DRUG LEVEL DECREASED 372 0.0365
189 INJECTION RELATED REACTION 60 0.0363
190 WHEEZING 2140 0.0361
191 THERAPY NON-RESPONDER 1587 0.0353
192 GENERAL PHYSICAL HEALTH DETERIORATION 4048 0.0350
193 PRODUCT DOSE OMISSION ISSUE 10267 0.0349
194 SPINAL FUSION SURGERY 141 0.0347
195 MALIGNANT MELANOMA IN SITU 43 0.0347
196 ADENOCARCINOMA OF COLON 65 0.0347
197 COLOSTOMY 68 0.0346
198 ROAD TRAFFIC ACCIDENT 1443 0.0345
199 PROSTATE INFECTION 33 0.0343
200 INFECTED CYST 41 0.0342
201 ILL-DEFINED DISORDER 2060 0.0339
202 LIQUID PRODUCT PHYSICAL ISSUE 247 0.0338
203 DERMATITIS PSORIASIFORM 69 0.0337
204 MATERNAL EXPOSURE DURING PREGNANCY 3007 0.0337
205 GASTROINTESTINAL STOMA COMPLICATION 53 0.0337
206 ABSCESS 537 0.0336
207 INTESTINAL ULCER 52 0.0327
208 PERTUSSIS 34 0.0326
209 SKIN NECROSIS 169 0.0325
210 LIVER DISORDER 1423 0.0321
211 FREQUENT BOWEL MOVEMENTS 863 0.0319
212 SQUAMOUS CELL CARCINOMA 300 0.0318
213 TONGUE DISORDER 230 0.0318
214 GANGRENE 191 0.0317
215 JOINT STIFFNESS 831 0.0316
216 OEDEMA 1711 0.0315
217 VEIN RUPTURE 52 0.0310
218 DRUG TOLERANCE 156 0.0308
219 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 71 0.0308
220 GASTROINTESTINAL BACTERIAL INFECTION 35 0.0306
221 DRUG LEVEL BELOW THERAPEUTIC 168 0.0304
222 LUNG DISORDER 1451 0.0296
223 SLEEP DISORDER 2071 0.0293
224 PRODUCT USE ISSUE 5476 0.0291
225 EAR INFECTION 772 0.0290
226 GENERAL SYMPTOM 216 0.0288
227 SINUSITIS 2950 0.0288
228 GASTROINTESTINAL DISORDER 2533 0.0282
229 POSTOPERATIVE WOUND INFECTION 190 0.0281
230 CERVICAL DYSPLASIA 61 0.0279
231 INTESTINAL DILATATION 37 0.0277
232 PRODUCT LABEL ISSUE 187 0.0275
233 DRUG-INDUCED LIVER INJURY 864 0.0275
234 INFLAMMATORY BOWEL DISEASE 269 0.0275
235 SENSORY LOSS 220 0.0273
236 JOINT DESTRUCTION 42 0.0270
237 FEMALE GENITAL TRACT FISTULA 46 0.0269
238 INTENTIONAL PRODUCT USE ISSUE 2359 0.0269
239 MUCOUS STOOLS 132 0.0266
240 MYOSITIS 239 0.0266
241 TOOTH ABSCESS 269 0.0264
242 DELIRIUM 909 0.0262
243 ABDOMINAL DISCOMFORT 4391 0.0262
244 NORMAL NEWBORN 142 0.0261
245 TASTE DISORDER 529 0.0260
246 ADVERSE REACTION 344 0.0259
247 GASTROINTESTINAL INFLAMMATION 203 0.0259
248 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 444 0.0259
249 MUSCULOSKELETAL PAIN 1354 0.0258
250 PREGNANCY 515 0.0257
251 TONSILLITIS 134 0.0257
252 SUBCUTANEOUS ABSCESS 123 0.0256
253 PRODUCT DOSE OMISSION 1671 0.0256
254 HYPERSENSITIVITY 4746 0.0255
255 DISABILITY 504 0.0255
256 DRUG ERUPTION 451 0.0254
257 DERMATITIS EXFOLIATIVE GENERALISED 87 0.0250
258 INFECTION 3610 0.0249
259 SKIN PLAQUE 207 0.0245
260 PRODUCT PACKAGING ISSUE 233 0.0245
261 THERAPEUTIC RESPONSE DECREASED 1479 0.0244
262 LARGE INTESTINAL ULCER 66 0.0243
263 PROCTITIS 68 0.0243
264 CLOSTRIDIUM DIFFICILE INFECTION 525 0.0240
265 EPILEPSY 721 0.0236
266 ALOPECIA 4622 0.0235
267 MUSCLE SPASTICITY 287 0.0233
268 HEMIPLEGIA 194 0.0233
269 ARTERIAL OCCLUSIVE DISEASE 183 0.0233
270 INCORRECT PRODUCT STORAGE 304 0.0231
271 PAPILLOMA VIRAL INFECTION 38 0.0230
272 SINUS CONGESTION 310 0.0229
273 DRUG SPECIFIC ANTIBODY PRESENT 147 0.0226
274 DEVICE ISSUE 2021 0.0225
275 IGA NEPHROPATHY 37 0.0223
276 CHOLANGIOCARCINOMA 33 0.0221
277 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1562 0.0219
278 SALMONELLOSIS 37 0.0219
279 HEPATIC FIBROSIS 75 0.0218
280 ARTHRITIS 1716 0.0218
281 GASTROINTESTINAL INFECTION 195 0.0217
282 POST PROCEDURAL INFECTION 176 0.0216
283 ENTERITIS 135 0.0211
284 SKIN HAEMORRHAGE 310 0.0209
285 CONTUSION 1999 0.0207
286 INVASIVE DUCTAL BREAST CARCINOMA 56 0.0206
287 GRANULOMA 71 0.0205
288 ERYSIPELAS 103 0.0205
289 NASOPHARYNGITIS 3746 0.0203
290 DRY MOUTH 1646 0.0203
291 OSTEOPOROSIS 827 0.0201
292 KIDNEY INFECTION 393 0.0200
293 AFFECT LABILITY 190 0.0197
294 SMALL INTESTINAL OBSTRUCTION 242 0.0196
295 PRODUCT CONTAINER SEAL ISSUE 34 0.0195
296 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 928 0.0193
297 ANORECTAL DISORDER 38 0.0190
298 TENDONITIS 295 0.0190
299 VITAMIN B12 DEFICIENCY 77 0.0190
300 DEFAECATION URGENCY 133 0.0190
301 VARICELLA ZOSTER VIRUS INFECTION 39 0.0188
302 PERIPHERAL SWELLING 2889 0.0187
303 SUBILEUS 39 0.0187
304 URTICARIA 3135 0.0187
305 CYTOMEGALOVIRUS COLITIS 43 0.0187
306 MOTOR DYSFUNCTION 190 0.0186
307 ADVERSE EVENT 1717 0.0186
308 ABSCESS LIMB 79 0.0185
309 MALIGNANT MELANOMA 248 0.0185
310 ABDOMINAL INFECTION 47 0.0184
311 WEIGHT FLUCTUATION 192 0.0183
312 HYPOAESTHESIA 2716 0.0181
313 HIDRADENITIS 165 0.0181
314 JOINT ARTHROPLASTY 32 0.0179
315 SELF-MEDICATION 73 0.0177
316 CONDITION AGGRAVATED 5359 0.0176
317 CELLULITIS 888 0.0176
318 ANTINUCLEAR ANTIBODY POSITIVE 57 0.0175
319 ULCER 279 0.0175
320 SKIN INJURY 58 0.0175
321 POLYARTHRITIS 92 0.0174
322 UPPER RESPIRATORY TRACT INFECTION 805 0.0174
323 ADVERSE DRUG REACTION 1562 0.0174
324 FEAR OF INJECTION 124 0.0174
325 OBSTRUCTION 69 0.0173
326 MIGRAINE 1646 0.0172
327 OSTEOLYSIS 35 0.0171
328 SKIN INFECTION 192 0.0171
329 RHEUMATIC DISORDER 33 0.0171
330 GASTROINTESTINAL OBSTRUCTION 41 0.0170
331 DYSPEPSIA 1670 0.0170
332 INTESTINAL OBSTRUCTION 635 0.0168
333 CONFUSIONAL STATE 2718 0.0168
334 DIARRHOEA HAEMORRHAGIC 155 0.0166
335 RENAL NEOPLASM 35 0.0165
336 DYSCHEZIA 50 0.0164
337 EAR PAIN 318 0.0163
338 HEPATITIS 417 0.0163
339 ERYTHEMA NODOSUM 57 0.0162
340 ANAL FISSURE 87 0.0162
341 HYPERTENSION 3418 0.0161
342 EXPOSURE VIA BREAST MILK 64 0.0161
343 HEPATIC STEATOSIS 298 0.0160
344 GASTRIC INFECTION 61 0.0159
345 PRODUCT STORAGE ERROR 1389 0.0159
346 DEMYELINATION 65 0.0158
347 RECTAL CANCER 48 0.0156
348 UNDERDOSE 1139 0.0156
349 SUSPECTED COVID-19 51 0.0154
350 VITILIGO 36 0.0153
351 INFLAMMATORY MARKER INCREASED 76 0.0153
352 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2758 0.0153
353 BACK DISORDER 247 0.0152
354 VARICELLA 36 0.0151
355 LYME DISEASE 50 0.0150
356 SKIN PAPILLOMA 60 0.0149
357 OFF LABEL USE 12962 0.0148
358 ADENOCARCINOMA 33 0.0147
359 HAEMATOCHEZIA 812 0.0147
360 ACCIDENTAL EXPOSURE TO PRODUCT 1505 0.0146
361 AMNESIA 949 0.0146
362 FACIAL PARALYSIS 124 0.0145
363 APPENDICITIS 134 0.0143
364 ARTHRALGIA 5952 0.0143
365 WEIGHT INCREASED 3181 0.0142
366 RESPIRATORY DISORDER 423 0.0141
367 RESPIRATORY TRACT CONGESTION 223 0.0140
368 DENGUE FEVER 32 0.0139
369 PUSTULE 33 0.0139
370 SINUS DISORDER 273 0.0138
371 LUNG ADENOCARCINOMA 41 0.0136
372 PNEUMONIA 4408 0.0136
373 RESPIRATORY TRACT INFECTION 353 0.0135
374 COORDINATION ABNORMAL 189 0.0135
375 HYPERCALCAEMIA 166 0.0134
376 CUSHINGOID 43 0.0134
377 GUILLAIN-BARRE SYNDROME 64 0.0132
378 RASH 5751 0.0132
379 SURGERY 763 0.0130
380 DERMATITIS EXFOLIATIVE 65 0.0130
381 CHOLECYSTITIS INFECTIVE 36 0.0130
382 RECTAL HAEMORRHAGE 551 0.0128
383 MUSCULAR WEAKNESS 1448 0.0127
384 APPENDICECTOMY 45 0.0126
385 APHTHOUS ULCER 96 0.0124
386 SKIN CANCER 266 0.0123
387 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 209 0.0123
388 CYSTITIS 390 0.0122
389 ASTHMA 1381 0.0122
390 COLITIS 461 0.0121
391 CLOSTRIDIAL INFECTION 41 0.0121
392 CUTANEOUS VASCULITIS 44 0.0120
393 STREPTOCOCCAL INFECTION 67 0.0120
394 DRUG DOSE OMISSION 1984 0.0120
395 VARICES OESOPHAGEAL 36 0.0119
396 PHARYNGITIS 147 0.0118
397 RASH PUSTULAR 86 0.0118
398 HYPERTRANSAMINASAEMIA 82 0.0118
399 SQUAMOUS CELL CARCINOMA OF SKIN 71 0.0117
400 ABDOMINAL PAIN UPPER 2410 0.0117
401 IRON DEFICIENCY ANAEMIA 108 0.0117
402 INTESTINAL PERFORATION 131 0.0117
403 PROCTALGIA 75 0.0117
404 PLANTAR FASCIITIS 39 0.0116
405 ABDOMINAL PAIN 2697 0.0116
406 LOCALISED INFECTION 280 0.0116
407 HEMIPARESIS 196 0.0116
408 DRUG INEFFECTIVE 15055 0.0114
409 SKIN ULCER 294 0.0114
410 NECK PAIN 634 0.0113
411 MEDICATION ERROR 626 0.0113
412 CHEMOTHERAPY 42 0.0111
413 FUNCTIONAL GASTROINTESTINAL DISORDER 38 0.0110
414 THERAPY CHANGE 108 0.0110
415 MELANOCYTIC NAEVUS 48 0.0109
416 DIVERTICULITIS 302 0.0109
417 IRON DEFICIENCY 49 0.0109
418 EATING DISORDER 231 0.0108
419 PYELONEPHRITIS 94 0.0108
420 WOUND COMPLICATION 37 0.0108
421 UVEITIS 146 0.0108
422 MEMORY IMPAIRMENT 1478 0.0107
423 HYSTERECTOMY 93 0.0107
424 SNEEZING 240 0.0107
425 FURUNCLE 84 0.0106
426 ARTHRITIS INFECTIVE 49 0.0106
427 BILE DUCT STONE 33 0.0104
428 PAIN 6347 0.0103
429 BRONCHITIS 764 0.0103
430 B-CELL LYMPHOMA 35 0.0103
431 SECRETION DISCHARGE 129 0.0103
432 HERPES VIRUS INFECTION 59 0.0102
433 DECREASED APPETITE 2375 0.0102
434 GASTROOESOPHAGEAL REFLUX DISEASE 810 0.0101
435 HEPATIC CYST 34 0.0100
436 CHEST PAIN 1854 0.0100
437 DRUG EFFECT DECREASED 539 0.0100
438 GASTROENTERITIS 146 0.0100
439 DEVICE MALFUNCTION 698 0.0099
440 MUSCLE SPASMS 1817 0.0099
441 SKIN DISORDER 330 0.0099
442 SYMPTOM RECURRENCE 59 0.0098
443 HEPATIC FUNCTION ABNORMAL 367 0.0098
444 OESOPHAGEAL CANDIDIASIS 39 0.0098
445 LYMPHOMA 151 0.0098
446 SARS-COV-2 TEST POSITIVE 129 0.0098
447 ANKYLOSING SPONDYLITIS 128 0.0097
448 PARAESTHESIA 1518 0.0096
449 INJECTION SITE REACTION 663 0.0096
450 TOOTH INFECTION 127 0.0096
451 RED CELL DISTRIBUTION WIDTH INCREASED 40 0.0096
452 PRODUCT USE IN UNAPPROVED INDICATION 2370 0.0096
453 PAIN IN EXTREMITY 2804 0.0095
454 ARTHRITIS BACTERIAL 39 0.0095
455 ARTHROPOD BITE 70 0.0094
456 PHARYNGITIS STREPTOCOCCAL 102 0.0094
457 PRURITUS 3609 0.0094
458 STAPHYLOCOCCAL INFECTION 309 0.0094
459 CARPAL TUNNEL SYNDROME 131 0.0093
460 OEDEMA PERIPHERAL 1139 0.0093
461 PRODUCT TEMPERATURE EXCURSION ISSUE 48 0.0093
462 PANCREATITIS 493 0.0093
463 PYREXIA 3220 0.0093
464 NONSPECIFIC REACTION 51 0.0093
465 NEPHROLITHIASIS 425 0.0093
466 ESCHERICHIA INFECTION 76 0.0092
467 LIVER FUNCTION TEST ABNORMAL 267 0.0092
468 VULVOVAGINAL MYCOTIC INFECTION 36 0.0091
469 HERPES ZOSTER 522 0.0091
470 FAECES SOFT 66 0.0091
471 INFLUENZA 1009 0.0090
472 VASCULAR DEVICE INFECTION 41 0.0090
473 SKIN LESION 247 0.0090
474 FATIGUE 7009 0.0090
475 HAEMORRHAGIC DIATHESIS 32 0.0090
476 HEPATOCELLULAR CARCINOMA 68 0.0089
477 WOUND SECRETION 35 0.0089
478 COLON CANCER 133 0.0089
479 BOWEL MOVEMENT IRREGULARITY 68 0.0089
480 CHOLELITHIASIS 291 0.0089
481 ANGINA PECTORIS 254 0.0089
482 POLYP 58 0.0088
483 SARCOIDOSIS 42 0.0088
484 RASH PRURITIC 479 0.0088
485 INTENTIONAL DOSE OMISSION 251 0.0088
486 DRUG EFFECT INCOMPLETE 319 0.0088
487 OSTEOMYELITIS 158 0.0087
488 INTRACRANIAL ANEURYSM 35 0.0087
489 MALAISE 3818 0.0087
490 PREMATURE LABOUR 49 0.0087
491 PULMONARY TUBERCULOSIS 37 0.0087
492 IMMUNE SYSTEM DISORDER 114 0.0086
493 HEADACHE 5422 0.0086
494 VIRAL UPPER RESPIRATORY TRACT INFECTION 41 0.0086
495 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 610 0.0086
496 SPINAL STENOSIS 35 0.0085
497 CERVIX CARCINOMA 33 0.0084
498 RHINITIS 68 0.0084
499 SHOULDER OPERATION 36 0.0084
500 GASTRIC DISORDER 287 0.0084
501 CHOLECYSTECTOMY 95 0.0083
502 STAPHYLOCOCCAL BACTERAEMIA 36 0.0083
503 INSOMNIA 2201 0.0083
504 THERAPY CESSATION 421 0.0082
505 EYE INFECTION 92 0.0081
506 HEPATITIS B 49 0.0081
507 HERNIA 156 0.0081
508 IMMUNOSUPPRESSION 71 0.0080
509 ABDOMINAL DISTENSION 840 0.0080
510 LUNG INFECTION 125 0.0080
511 INSURANCE ISSUE 123 0.0080
512 GAIT DISTURBANCE 1536 0.0080
513 DIVERTICULUM INTESTINAL 35 0.0080
514 ORAL CANDIDIASIS 105 0.0080
515 MALNUTRITION 89 0.0079
516 CONGESTIVE CARDIOMYOPATHY 33 0.0079
517 POOR QUALITY DRUG ADMINISTERED 51 0.0079
518 VISUAL IMPAIRMENT 965 0.0078
519 ANAL INCONTINENCE 70 0.0078
520 DEPRESSION 1763 0.0077
521 LYMPHADENOPATHY 272 0.0077
522 NEOPLASM 88 0.0076
523 ABDOMINAL TENDERNESS 38 0.0076
524 WHITE BLOOD CELL COUNT INCREASED 293 0.0076
525 JOINT INJURY 163 0.0076
526 BLOOD IRON DECREASED 90 0.0076
527 BLOOD PRESSURE DIASTOLIC INCREASED 35 0.0076
528 IMMUNODEFICIENCY 113 0.0076
529 DEVICE PHYSICAL PROPERTY ISSUE 58 0.0076
530 LABORATORY TEST ABNORMAL 223 0.0075
531 DIARRHOEA 4872 0.0075
532 BLOOD PRESSURE SYSTOLIC INCREASED 146 0.0075
533 VITAMIN D DEFICIENCY 73 0.0075
534 ABDOMINAL HERNIA 34 0.0074
535 IMPAIRED QUALITY OF LIFE 107 0.0074
536 POOR QUALITY PRODUCT ADMINISTERED 78 0.0074
537 THYROID CANCER 89 0.0074
538 HERPES SIMPLEX 48 0.0074
539 MENINGITIS 49 0.0073
540 DECREASED IMMUNE RESPONSIVENESS 72 0.0073
541 VOMITING 3445 0.0073
542 APHASIA 220 0.0073
543 ORAL HERPES 140 0.0072
544 BREAST MASS 48 0.0071
545 DEVICE RELATED INFECTION 110 0.0071
546 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 68 0.0071
547 PLEURISY 42 0.0071
548 FUNGAL INFECTION 235 0.0070
549 HOSPITALISATION 1082 0.0070
550 SKIN MASS 47 0.0070
551 HEPATIC ENZYME ABNORMAL 35 0.0070
552 KNEE OPERATION 69 0.0070
553 CANDIDA INFECTION 118 0.0070
554 GASTROENTERITIS VIRAL 126 0.0070
555 ABNORMAL FAECES 57 0.0069
556 CATARACT 414 0.0069
557 RENAL CELL CARCINOMA 34 0.0069
558 ILEUS 86 0.0069
559 PULMONARY MASS 103 0.0069
560 PEMPHIGOID 52 0.0069
561 MASS 96 0.0069
562 CYST 85 0.0068
563 HIP SURGERY 37 0.0068
564 WEIGHT DECREASED 1907 0.0068
565 TRANSAMINASES INCREASED 151 0.0068
566 FEELING HOT 416 0.0068
567 ALANINE AMINOTRANSFERASE INCREASED 416 0.0068
568 INFLUENZA LIKE ILLNESS 554 0.0067
569 NEOPLASM MALIGNANT 449 0.0067
570 GASTROINTESTINAL CARCINOMA 61 0.0067
571 SPINAL PAIN 78 0.0067
572 TENDON DISORDER 43 0.0066
573 CHOLECYSTITIS 78 0.0065
574 AUTOIMMUNE HEPATITIS 45 0.0065
575 PRODUCT PRESCRIBING ERROR 154 0.0065
576 POST PROCEDURAL COMPLICATION 124 0.0065
577 TENDERNESS 67 0.0064
578 URINARY TRACT INFECTION 1096 0.0064
579 ANAPHYLACTIC REACTION 353 0.0064
580 ABORTION SPONTANEOUS 255 0.0064
581 LARGE INTESTINE POLYP 44 0.0063
582 LARGE INTESTINE PERFORATION 44 0.0063
583 ANKLE FRACTURE 98 0.0063
584 SKIN EXFOLIATION 532 0.0063
585 FOETAL EXPOSURE DURING PREGNANCY 512 0.0063
586 VIRAL INFECTION 209 0.0063
587 ASPARTATE AMINOTRANSFERASE INCREASED 333 0.0063
588 SKIN LACERATION 68 0.0062
589 RHINORRHOEA 404 0.0062
590 OVARIAN CYST 62 0.0062
591 CORONAVIRUS INFECTION 41 0.0062
592 CHOLECYSTITIS ACUTE 35 0.0062
593 GENERALISED ERYTHEMA 35 0.0061
594 ASTHENIA 2298 0.0061
595 COVID-19 1070 0.0061
596 CONCUSSION 47 0.0061
597 INCONTINENCE 64 0.0060
598 HEPATITIS C 73 0.0060
599 SKIN WARM 35 0.0060
600 TREATMENT NONCOMPLIANCE 328 0.0060
601 HYPERKERATOSIS 33 0.0060
602 QUALITY OF LIFE DECREASED 80 0.0060
603 ADRENAL INSUFFICIENCY 72 0.0059
604 FLUID RETENTION 300 0.0059
605 GENERAL PHYSICAL CONDITION ABNORMAL 40 0.0059
606 DYSARTHRIA 221 0.0059
607 UROSEPSIS 54 0.0058
608 MUSCULOSKELETAL DISORDER 111 0.0058
609 ANXIETY 1650 0.0058
610 LUNG NEOPLASM MALIGNANT 237 0.0058
611 PRODUCT COMPLAINT 146 0.0058
612 VASCULITIS 67 0.0057
613 NAUSEA 4544 0.0057
614 UTERINE CANCER 46 0.0057
615 SEPSIS 638 0.0057
616 DERMATITIS 119 0.0057
617 DIZZINESS 2826 0.0057
618 BRAIN NEOPLASM 52 0.0057
619 HAEMORRHOIDS 110 0.0056
620 DYSPNOEA 3173 0.0056
621 TRANSIENT ISCHAEMIC ATTACK 189 0.0056
622 SKIN REACTION 78 0.0055
623 PAPULE 39 0.0055
624 PRODUCT DISTRIBUTION ISSUE 51 0.0055
625 SCAB 62 0.0054
626 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 298 0.0054
627 DUODENAL ULCER 38 0.0054
628 PRODUCT ADMINISTRATION ERROR 108 0.0053
629 COVID-19 PNEUMONIA 63 0.0053
630 NERVE COMPRESSION 49 0.0053
631 NERVE INJURY 59 0.0053
632 APPETITE DISORDER 35 0.0053
633 GASTROINTESTINAL PAIN 58 0.0053
634 CEREBROVASCULAR ACCIDENT 893 0.0053
635 CHEST DISCOMFORT 537 0.0052
636 GOUT 94 0.0052
637 BACTERAEMIA 62 0.0052
638 PROCEDURAL COMPLICATION 40 0.0052
639 THERAPY PARTIAL RESPONDER 81 0.0052
640 CYTOMEGALOVIRUS INFECTION 86 0.0052
641 TACHYCARDIA 459 0.0052
642 SPINAL OPERATION 63 0.0051
643 PRODUCT QUALITY ISSUE 694 0.0051
644 DEVICE LEAKAGE 221 0.0051
645 ANGINA UNSTABLE 33 0.0051
646 JOINT EFFUSION 35 0.0051
647 GAMMA-GLUTAMYLTRANSFERASE INCREASED 111 0.0050
648 CARDIAC OPERATION 43 0.0050
649 MOUTH ULCERATION 105 0.0050
650 OROPHARYNGEAL PAIN 460 0.0050
651 PRODUCT DISPENSING ERROR 108 0.0050
652 BACTERIAL INFECTION 92 0.0049
653 EPISTAXIS 368 0.0049
654 CLOSTRIDIUM DIFFICILE COLITIS 52 0.0049
655 PRODUCT CONTAINER ISSUE 42 0.0049
656 CAESAREAN SECTION 57 0.0049
657 COMPLICATION ASSOCIATED WITH DEVICE 71 0.0049
658 ABNORMAL LOSS OF WEIGHT 33 0.0048
659 PAIN OF SKIN 130 0.0048
660 GALLBLADDER DISORDER 86 0.0048
661 PANCREATITIS ACUTE 108 0.0048
662 BREAST CANCER 446 0.0048
663 SKIN FISSURES 93 0.0048
664 HYPERAESTHESIA 39 0.0047
665 SPLENOMEGALY 55 0.0047
666 ABDOMINAL PAIN LOWER 117 0.0046
667 PNEUMONIA BACTERIAL 42 0.0046
668 SLEEP APNOEA SYNDROME 87 0.0046
669 LEUKAEMIA 43 0.0046
670 BLOOD ALBUMIN DECREASED 36 0.0045
671 NODULE 58 0.0044
672 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 231 0.0044
673 THERAPEUTIC RESPONSE SHORTENED 146 0.0044
674 PHARYNGEAL SWELLING 43 0.0044
675 INTERVERTEBRAL DISC PROTRUSION 96 0.0044
676 PNEUMOCYSTIS JIROVECII PNEUMONIA 44 0.0044
677 UTERINE LEIOMYOMA 32 0.0044
678 BLOOD DISORDER 35 0.0044
679 THROAT TIGHTNESS 118 0.0044
680 AORTIC ANEURYSM 33 0.0043
681 NEUTROPHIL COUNT INCREASED 44 0.0043
682 BODY TEMPERATURE INCREASED 87 0.0043
683 HYPOALBUMINAEMIA 33 0.0042
684 MYASTHENIA GRAVIS 34 0.0042
685 DIABETES MELLITUS 319 0.0042
686 TOOTH EXTRACTION 52 0.0042
687 ERYTHEMA 853 0.0041
688 FOOT FRACTURE 78 0.0041
689 FALL 1363 0.0041
690 LIMB INJURY 107 0.0039
691 SPINAL DISORDER 37 0.0039
692 THERAPY INTERRUPTED 279 0.0039
693 BACK PAIN 901 0.0039
694 ACNE 294 0.0039
695 HEPATOMEGALY 38 0.0039
696 ACUTE CORONARY SYNDROME 32 0.0039
697 WRIST FRACTURE 46 0.0038
698 HYPOKINESIA 55 0.0038
699 LEUKOPENIA 189 0.0038
700 HEPATOTOXICITY 84 0.0038
701 PHOTOSENSITIVITY REACTION 62 0.0038
702 OPTIC NEURITIS 34 0.0037
703 GASTRITIS 98 0.0037
704 PHOTOPHOBIA 70 0.0037
705 CONJUNCTIVITIS 69 0.0037
706 OVARIAN CANCER 34 0.0037
707 ILLNESS 378 0.0037
708 BLOOD CREATININE INCREASED 237 0.0036
709 INCORRECT PRODUCT ADMINISTRATION DURATION 78 0.0036
710 INCORRECT DOSE ADMINISTERED 821 0.0036
711 DEVICE OCCLUSION 50 0.0035
712 DEMENTIA 99 0.0035
713 LYMPHOPENIA 50 0.0035
714 PROSTATE CANCER 284 0.0035
715 SCAR 60 0.0035
716 MYALGIA 591 0.0035
717 ISCHAEMIC STROKE 62 0.0035
718 BLOOD PRESSURE INCREASED 531 0.0035
719 ASPIRATION 38 0.0035
720 BREAST CANCER STAGE I 32 0.0034
721 BLOOD TRIGLYCERIDES INCREASED 61 0.0034
722 SYNCOPE 344 0.0034
723 ACCIDENT 41 0.0034
724 BLADDER DISORDER 34 0.0034
725 PROSTATIC SPECIFIC ANTIGEN INCREASED 47 0.0034
726 HALLUCINATION, AUDITORY 54 0.0034
727 INTERSTITIAL LUNG DISEASE 164 0.0034
728 MUSCULOSKELETAL CHEST PAIN 52 0.0034
729 BODY TEMPERATURE DECREASED 33 0.0033
730 COUGH 936 0.0033
731 LIGAMENT SPRAIN 33 0.0033
732 NEURALGIA 81 0.0033
733 PALPITATIONS 390 0.0033
734 TENDON RUPTURE 41 0.0033
735 MYOCARDIAL INFARCTION 579 0.0033
736 UNEVALUABLE EVENT 251 0.0033
737 HYPERSOMNIA 95 0.0033
738 ECZEMA 173 0.0033
739 GASTRIC ULCER 62 0.0033
740 PREMATURE BABY 98 0.0033
741 DYSPHAGIA 309 0.0033
742 PARANOIA 56 0.0032
743 PERITONITIS 67 0.0032
744 BEDRIDDEN 42 0.0032
745 CARDIOMYOPATHY 47 0.0032
746 HYPERTHYROIDISM 46 0.0032
747 NASAL CONGESTION 186 0.0032
748 DENTAL CARIES 35 0.0032
749 PNEUMOTHORAX 50 0.0031
750 SWELLING FACE 205 0.0031
751 SUBARACHNOID HAEMORRHAGE 32 0.0031
752 HAEMORRHAGE 327 0.0031
753 SEPTIC SHOCK 136 0.0031
754 VERTIGO 190 0.0031
755 MULTIPLE SCLEROSIS 149 0.0031
756 DRUG EFFECT LESS THAN EXPECTED 46 0.0031
757 ACUTE MYOCARDIAL INFARCTION 91 0.0031
758 SCRATCH 32 0.0030
759 RIB FRACTURE 62 0.0030
760 NERVOUS SYSTEM DISORDER 94 0.0030
761 POLYNEUROPATHY 36 0.0030
762 INJURY ASSOCIATED WITH DEVICE 61 0.0030
763 BURNING SENSATION 210 0.0030
764 DEEP VEIN THROMBOSIS 194 0.0030
765 MYOCARDITIS 34 0.0030
766 UPPER LIMB FRACTURE 59 0.0030
767 BLOOD URINE PRESENT 56 0.0029
768 PULMONARY EMBOLISM 277 0.0029
769 SEIZURE 335 0.0029
770 MENTAL DISORDER 126 0.0029
771 ACUTE MYELOID LEUKAEMIA 45 0.0029
772 LOSS OF CONSCIOUSNESS 368 0.0029
773 DERMATITIS ALLERGIC 36 0.0029
774 PRODUCT USE COMPLAINT 45 0.0029
775 RASH ERYTHEMATOUS 136 0.0028
776 DISEASE RECURRENCE 135 0.0028
777 PLATELET COUNT INCREASED 37 0.0028
778 CEREBRAL INFARCTION 69 0.0028
779 DEAFNESS 73 0.0028
780 THROMBOSIS 224 0.0028
781 BLOOD TEST ABNORMAL 39 0.0028
782 IMPAIRED WORK ABILITY 59 0.0028
783 ANAPHYLACTIC SHOCK 71 0.0028
784 HEPATIC CANCER 66 0.0027
785 PULMONARY CONGESTION 36 0.0027
786 HEAD INJURY 86 0.0027
787 INJECTION SITE HAEMORRHAGE 217 0.0027
788 PARAESTHESIA ORAL 39 0.0027
789 HIATUS HERNIA 35 0.0027
790 OSTEOPENIA 41 0.0027
791 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 547 0.0027
792 BRAIN OEDEMA 34 0.0027
793 FLATULENCE 152 0.0027
794 SKIN DISCOLOURATION 123 0.0027
795 MUSCULOSKELETAL DISCOMFORT 46 0.0027
796 SWOLLEN TONGUE 83 0.0027
797 TOOTH DISORDER 59 0.0027
798 ROTATOR CUFF SYNDROME 34 0.0026
799 SPINAL FRACTURE 53 0.0026
800 SENSORY DISTURBANCE 42 0.0026
801 DRUG RESISTANCE 67 0.0026
802 INJECTION SITE RASH 80 0.0026
803 POOR QUALITY SLEEP 56 0.0026
804 PANCREATIC CARCINOMA 75 0.0026
805 RENAL DISORDER 121 0.0026
806 PRURITUS GENERALISED 56 0.0026
807 THERAPEUTIC RESPONSE UNEXPECTED 116 0.0026
808 PRODUCT PHYSICAL ISSUE 52 0.0026
809 FLUSHING 262 0.0026
810 DEHYDRATION 343 0.0026
811 LETHARGY 146 0.0025
812 INCORRECT DOSE ADMINISTERED BY DEVICE 66 0.0025
813 RASH MACULAR 88 0.0025
814 ANAEMIA 478 0.0025
815 INTRAOCULAR PRESSURE INCREASED 32 0.0025
816 DEVICE USE ERROR 87 0.0025
817 EYE SWELLING 93 0.0025
818 MYELODYSPLASTIC SYNDROME 36 0.0025
819 HIP FRACTURE 80 0.0025
820 INJECTION SITE SWELLING 190 0.0025
821 THROAT IRRITATION 111 0.0025
822 PRODUCTIVE COUGH 118 0.0025
823 RENAL IMPAIRMENT 207 0.0025
824 INCORRECT ROUTE OF DRUG ADMINISTRATION 88 0.0025
825 EOSINOPHILIA 43 0.0025
826 DEPRESSED MOOD 129 0.0024
827 COLD SWEAT 43 0.0024
828 PNEUMONITIS 66 0.0024
829 LIMB DISCOMFORT 75 0.0024
830 ASCITES 71 0.0024
831 VISION BLURRED 331 0.0024
832 PSYCHOTIC DISORDER 71 0.0024
833 DRY SKIN 320 0.0024
834 RASH GENERALISED 62 0.0024
835 ACUTE RESPIRATORY FAILURE 46 0.0024
836 ATRIAL FIBRILLATION 232 0.0024
837 ACUTE RESPIRATORY DISTRESS SYNDROME 42 0.0024
838 DIABETES MELLITUS INADEQUATE CONTROL 42 0.0024
839 PANIC ATTACK 84 0.0023
840 PRESYNCOPE 56 0.0023
841 THROMBOCYTOPENIA 257 0.0023
842 GASTRIC CANCER 58 0.0023
843 CARDIAC FAILURE 183 0.0023
844 HAEMATURIA 78 0.0023
845 INJECTION SITE PAIN 695 0.0023
846 MUCOSAL INFLAMMATION 59 0.0023
847 BLOOD POTASSIUM DECREASED 67 0.0022
848 HYPERHIDROSIS 287 0.0022
849 BLINDNESS 90 0.0022
850 PROCEDURAL PAIN 61 0.0022
851 MIDDLE INSOMNIA 41 0.0022
852 TUBULOINTERSTITIAL NEPHRITIS 41 0.0022
853 RASH PAPULAR 49 0.0022
854 ANGIOEDEMA 96 0.0022
855 FRACTURE 41 0.0022
856 HOT FLUSH 163 0.0022
857 EYE DISORDER 71 0.0022
858 DYSSTASIA 63 0.0022
859 MOVEMENT DISORDER 69 0.0021
860 FAECES DISCOLOURED 46 0.0021
861 TOOTHACHE 38 0.0021
862 HAEMOGLOBIN DECREASED 215 0.0021
863 CHILLS 244 0.0021
864 CARDIOVASCULAR DISORDER 52 0.0020
865 CONSTIPATION 446 0.0020
866 LEUKOCYTOSIS 37 0.0020
867 HYPOTHYROIDISM 65 0.0020
868 HEAD DISCOMFORT 36 0.0020
869 INJECTION SITE BRUISING 162 0.0020
870 BONE DISORDER 37 0.0020
871 DYSPHONIA 118 0.0020
872 THIRST 36 0.0020
873 HEART RATE INCREASED 199 0.0020
874 FEELING ABNORMAL 480 0.0020
875 ERECTILE DYSFUNCTION 51 0.0020
876 PLASMA CELL MYELOMA 77 0.0020
877 NEUROPATHY PERIPHERAL 187 0.0020
878 MUSCLE TWITCHING 45 0.0020
879 BLOOD ALKALINE PHOSPHATASE INCREASED 48 0.0019
880 INTENTIONAL PRODUCT MISUSE 169 0.0019
881 DRUG PRESCRIBING ERROR 37 0.0019
882 OSTEONECROSIS 63 0.0019
883 BLOOD PRESSURE FLUCTUATION 46 0.0019
884 INJECTION SITE ERYTHEMA 235 0.0019
885 BLOOD PRESSURE ABNORMAL 37 0.0019
886 HEPATIC FAILURE 56 0.0019
887 DIPLOPIA 48 0.0018
888 PALLOR 50 0.0018
889 DEVICE USE ISSUE 32 0.0018
890 MELAENA 40 0.0018
891 HEART RATE IRREGULAR 41 0.0018
892 EXPOSURE VIA SKIN CONTACT 47 0.0018
893 DRY EYE 90 0.0018
894 HYPOKALAEMIA 82 0.0018
895 CEREBRAL HAEMORRHAGE 63 0.0018
896 PRODUCT PRESCRIBING ISSUE 38 0.0017
897 DRUG DOSE OMISSION BY DEVICE 136 0.0017
898 RENAL CANCER 82 0.0017
899 LACRIMATION INCREASED 52 0.0017
900 INJECTION SITE PRURITUS 115 0.0017
901 SUICIDAL IDEATION 157 0.0017
902 EXPIRED PRODUCT ADMINISTERED 57 0.0017
903 PRODUCT AVAILABILITY ISSUE 39 0.0017
904 CARDIAC DISORDER 160 0.0017
905 SKIN BURNING SENSATION 122 0.0017
906 BLOOD CREATINE PHOSPHOKINASE INCREASED 49 0.0017
907 BLADDER CANCER 100 0.0017
908 ARRHYTHMIA 80 0.0017
909 PERICARDIAL EFFUSION 39 0.0017
910 BONE PAIN 98 0.0017
911 PLEURAL EFFUSION 101 0.0017
912 HAEMATOMA 43 0.0017
913 MULTIPLE ORGAN DYSFUNCTION SYNDROME 47 0.0017
914 LIP SWELLING 55 0.0016
915 INJECTION SITE MASS 60 0.0016
916 CARDIAC FAILURE CONGESTIVE 130 0.0016
917 FEEDING DISORDER 32 0.0016
918 SKIN IRRITATION 72 0.0016
919 MOOD SWINGS 49 0.0015
920 HYPOACUSIS 66 0.0015
921 EYE PAIN 86 0.0015
922 PNEUMONIA ASPIRATION 38 0.0015
923 GLYCOSYLATED HAEMOGLOBIN INCREASED 38 0.0015
924 DYSURIA 55 0.0015
925 JAUNDICE 40 0.0015
926 RESPIRATORY DISTRESS 41 0.0015
927 DEATH 1278 0.0015
928 OVERDOSE 319 0.0015
929 NERVOUSNESS 77 0.0015
930 RED BLOOD CELL COUNT DECREASED 42 0.0015
931 GASTROINTESTINAL HAEMORRHAGE 121 0.0014
932 MENTAL IMPAIRMENT 35 0.0014
933 RESPIRATORY FAILURE 105 0.0014
934 POLLAKIURIA 60 0.0014
935 TINNITUS 66 0.0014
936 SPEECH DISORDER 74 0.0014
937 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 41 0.0014
938 RENAL FAILURE 185 0.0014
939 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 64 0.0014
940 BLOOD BILIRUBIN INCREASED 37 0.0014
941 FEELING COLD 38 0.0014
942 HEART RATE DECREASED 47 0.0013
943 HYPOPHAGIA 34 0.0013
944 FEMUR FRACTURE 41 0.0013
945 PULMONARY OEDEMA 59 0.0013
946 HYPOTENSION 264 0.0013
947 EYE PRURITUS 44 0.0013
948 ENCEPHALOPATHY 32 0.0013
949 CORONARY ARTERY DISEASE 39 0.0013
950 TREMOR 213 0.0013
951 BLOOD PRESSURE DECREASED 85 0.0013
952 WHITE BLOOD CELL COUNT DECREASED 138 0.0013
953 OCULAR HYPERAEMIA 60 0.0013
954 URINARY RETENTION 42 0.0013
955 DISORIENTATION 49 0.0012
956 ACUTE KIDNEY INJURY 185 0.0012
957 DYSPNOEA EXERTIONAL 45 0.0012
958 BALANCE DISORDER 103 0.0012
959 EMOTIONAL DISTRESS 129 0.0011
960 DISEASE PROGRESSION 126 0.0011
961 SOMNOLENCE 201 0.0010
962 PRODUCT SUBSTITUTION ISSUE 57 0.0010
963 COMA 47 0.0010
964 DYSGEUSIA 73 0.0010
965 CHRONIC KIDNEY DISEASE 73 0.0010
966 BLOOD GLUCOSE INCREASED 181 0.0010
967 CARDIAC ARREST 76 0.0009
968 DEVICE BREAKAGE 37 0.0009
969 DISTURBANCE IN ATTENTION 48 0.0009
970 CARDIO-RESPIRATORY ARREST 36 0.0009
971 PLATELET COUNT DECREASED 91 0.0009
972 DERMATITIS ATOPIC 43 0.0008
973 HYPOGLYCAEMIA 38 0.0008
974 SUICIDE ATTEMPT 47 0.0008
975 EYE IRRITATION 44 0.0008
976 PANCYTOPENIA 42 0.0008
977 OXYGEN SATURATION DECREASED 41 0.0007
978 COGNITIVE DISORDER 33 0.0007
979 BLOOD GLUCOSE DECREASED 33 0.0007
980 DRUG INTERACTION 106 0.0007
981 NEUTROPENIA 88 0.0006
982 IRRITABILITY 38 0.0006
983 HALLUCINATION 46 0.0006
984 NO ADVERSE EVENT 97 0.0005
985 AGITATION 39 0.0005
986 DEVICE DIFFICULT TO USE 33 0.0005
987 TOXICITY TO VARIOUS AGENTS 46 0.0003